The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disease outcomes by race in patients with high-risk triple negative breast cancer with residual disease after neoadjuvant chemotherapy: A post-hoc analysis of the EA1131 randomized clinical trial.
 
Olga Kantor
No Relationships to Disclose
 
Lisa A. Newman
Research Funding - Genentech
 
Lauren K Anderson
No Relationships to Disclose
 
Charity Glass
No Relationships to Disclose
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Diaccurate; Gilead Sciences; Lilly; Novartis
 
Esther R. Ogayo
No Relationships to Disclose
 
Mariana Chavez-MacGregor
Consulting or Advisory Role - Abbott; AstraZeneca; Exact Sciences; Lilly O.; Novartis; Pfizer; Roche
Research Funding - Novartis; Pfizer
 
Rachel A. Freedman
Employment - Firefly Health (I)
Stock and Other Ownership Interests - Firefly Health (I)
Research Funding - Eisai (Inst); Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Tari A. King
Honoraria - Genomic Health
Consulting or Advisory Role - Besins Healthcare; Exact Sciences; Genomic Health
Travel, Accommodations, Expenses - Grupo Oncoclinicas
Other Relationship - Precisca
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - BioNTech SE; Merck
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Roche/Genentech